WO1996032403A3 - Novel cytosine and cytidine derivatives - Google Patents
Novel cytosine and cytidine derivatives Download PDFInfo
- Publication number
- WO1996032403A3 WO1996032403A3 PCT/EP1996/001595 EP9601595W WO9632403A3 WO 1996032403 A3 WO1996032403 A3 WO 1996032403A3 EP 9601595 W EP9601595 W EP 9601595W WO 9632403 A3 WO9632403 A3 WO 9632403A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cytidine derivatives
- cytosine
- novel
- novel cytosine
- cytidine
- Prior art date
Links
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 title abstract 4
- UHDGCWIWMRVCDJ-ZAKLUEHWSA-N cytidine Chemical class O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-ZAKLUEHWSA-N 0.000 title abstract 2
- 229940104302 cytosine Drugs 0.000 title abstract 2
- 239000003814 drug Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/14—Pyrrolo-pyrimidine radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU54000/96A AU5400096A (en) | 1995-04-12 | 1996-04-12 | Novel cytosine and cytidine derivatives |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19514523.2 | 1995-04-12 | ||
DE1995114523 DE19514523A1 (en) | 1995-04-12 | 1995-04-12 | New cytosine and cytidine derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1996032403A2 WO1996032403A2 (en) | 1996-10-17 |
WO1996032403A3 true WO1996032403A3 (en) | 1996-11-28 |
Family
ID=7759937
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP1996/001595 WO1996032403A2 (en) | 1995-04-12 | 1996-04-12 | Novel cytosine and cytidine derivatives |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU5400096A (en) |
DE (1) | DE19514523A1 (en) |
WO (1) | WO1996032403A2 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8841275B2 (en) | 2010-11-30 | 2014-09-23 | Gilead Pharmasset Llc | 2′-spiro-nucleosides and derivatives thereof useful for treating hepatitis C virus and dengue virus infections |
US8957046B2 (en) | 2007-03-30 | 2015-02-17 | Gilead Pharmasset Llc | Nucleoside phosphoramidate prodrugs |
US9045520B2 (en) | 2008-12-23 | 2015-06-02 | Gilead Pharmasset Llc | Synthesis of purine nucleosides |
US9393256B2 (en) | 2011-09-16 | 2016-07-19 | Gilead Pharmasset Llc | Methods for treating HCV |
US9549941B2 (en) | 2011-11-29 | 2017-01-24 | Gilead Pharmasset Llc | Compositions and methods for treating hepatitis C virus |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI1633766T1 (en) | 2003-05-30 | 2019-06-28 | Gilead Pharmasset Llc | Modified fluorinated nucleoside analogues |
NZ554442A (en) | 2004-09-14 | 2011-05-27 | Pharmasset Inc | Preparation of 2'fluoro-2'-alkyl-substituted or other optionally substituted ribofuranosyl pyrimidines and purines and their derivatives |
MX2011006891A (en) | 2008-12-23 | 2011-10-06 | Pharmasset Inc | Nucleoside phosphoramidates. |
EA201100851A1 (en) | 2008-12-23 | 2012-04-30 | Фармассет, Инк. | NUCLEOSIDE ANALOGUES |
US8618076B2 (en) | 2009-05-20 | 2013-12-31 | Gilead Pharmasset Llc | Nucleoside phosphoramidates |
TWI583692B (en) | 2009-05-20 | 2017-05-21 | 基利法瑪席特有限責任公司 | Nucleoside phosphoramidates |
EP2552931B1 (en) | 2010-03-31 | 2014-07-23 | Gilead Pharmasset LLC | Stereoselective synthesis of phosphorus containing actives |
MY172166A (en) | 2013-01-31 | 2019-11-15 | Gilead Pharmasset Llc | Combination formulation of two antiviral compounds |
PT3038601T (en) | 2013-08-27 | 2020-06-30 | Gilead Pharmasset Llc | Combination formulation of two antiviral compounds |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62255499A (en) * | 1986-04-28 | 1987-11-07 | Teijin Ltd | Fluorescent nucleoside or nucleotide |
WO1991011186A1 (en) * | 1990-02-01 | 1991-08-08 | Emory University | Method and compositions for the synthesis of bch-189 and related compounds |
-
1995
- 1995-04-12 DE DE1995114523 patent/DE19514523A1/en not_active Withdrawn
-
1996
- 1996-04-12 AU AU54000/96A patent/AU5400096A/en not_active Withdrawn
- 1996-04-12 WO PCT/EP1996/001595 patent/WO1996032403A2/en active Search and Examination
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62255499A (en) * | 1986-04-28 | 1987-11-07 | Teijin Ltd | Fluorescent nucleoside or nucleotide |
WO1991011186A1 (en) * | 1990-02-01 | 1991-08-08 | Emory University | Method and compositions for the synthesis of bch-189 and related compounds |
Non-Patent Citations (5)
Title |
---|
BRODFUEHRER P.R. ET AL: "A Practical Synthesis of (S)-HPMPC", TETRAHEDRON LETTERS, vol. 35, no. 20, 1994, OXFORD GB, pages 3243 - 3246, XP002012084 * |
ELEVENTH INTERNATIONAL ROUND TABLE ON NUCLEOSIDES, NUCLEOTIDES AND THEIR BIOLOGICAL APPLICATIONS, 7 September 1994 (1994-09-07) - 11 September 1994 (1994-09-11), LEUVEN, BE * |
HARNDEN M.R. ET AL: "Novel Acyclonucleotides: Synthesis and Antiviral Activity of Alkenylphosponic Acid Derivatives of Purines and a Pyrimidine", JOURNAL OF MEDICINAL CHEMISTRY, vol. 36, 1993, WASHINGTON US, pages 1343 - 1355, XP002012083 * |
LOAKES, D. ET AL: "The synthesis of bicyclic N4-amino-2'-deoxycytidine derivatives", NUCLEOSIDES NUCLEOTIDES, vol. 14, no. 3-5, May 1995 (1995-05-01), pages 291 - 293, XP002013445 * |
PATENT ABSTRACTS OF JAPAN vol. 012, no. 139 (C - 491) 27 April 1988 (1988-04-27) * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8957046B2 (en) | 2007-03-30 | 2015-02-17 | Gilead Pharmasset Llc | Nucleoside phosphoramidate prodrugs |
US9045520B2 (en) | 2008-12-23 | 2015-06-02 | Gilead Pharmasset Llc | Synthesis of purine nucleosides |
US8841275B2 (en) | 2010-11-30 | 2014-09-23 | Gilead Pharmasset Llc | 2′-spiro-nucleosides and derivatives thereof useful for treating hepatitis C virus and dengue virus infections |
US9394331B2 (en) | 2010-11-30 | 2016-07-19 | Gilead Pharmasset Llc | 2′-spiro-nucleosides and derivatives thereof useful for treating hepatitis C virus and dengue virus infections |
US9393256B2 (en) | 2011-09-16 | 2016-07-19 | Gilead Pharmasset Llc | Methods for treating HCV |
US9549941B2 (en) | 2011-11-29 | 2017-01-24 | Gilead Pharmasset Llc | Compositions and methods for treating hepatitis C virus |
Also Published As
Publication number | Publication date |
---|---|
AU5400096A (en) | 1996-10-30 |
DE19514523A1 (en) | 1996-10-17 |
WO1996032403A2 (en) | 1996-10-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU7693396A (en) | Poly(9,9'-spiro-bisfluorenes), the production and use of same | |
AU1231492A (en) | Substituted phenyl-1,3 dioxoloquinoline derivatives and their use as antitumor agents | |
AU5772196A (en) | 3,4-disubstituted-phenylsulphonamides and their therapeutic use | |
IL119488A (en) | Substituted 2, 4-imidazolidinediones, their production and pharmaceutical compositions containing them | |
CA2219818A1 (en) | Novel compounds, the preparation and use thereof | |
PL324992A1 (en) | Novel derivatives of 2,3-dioxotetrahydoquinoxaline | |
AU5772296A (en) | 3,4-disubstituted-phenylsulphonamides and their therapeutic use | |
HUP9903707A3 (en) | Lactone derivatives of 17.beta.-carboxy,carbothio and amide androstane derivatives, their production, use thereof and medicament containing them | |
AU3284395A (en) | Synthesis of 1,1,1,3,3,-pentafluoropropane | |
AU6636598A (en) | Novel 3,4-dialkoxyphenyl derivatives and the use thereof | |
AU4329396A (en) | Use of 3,4-diphenylchromans | |
WO1996032403A3 (en) | Novel cytosine and cytidine derivatives | |
AU640820B2 (en) | 1,3-benzoxazine derivatives, their production and use | |
HUP9802807A3 (en) | 1,3,8-triazo-spiro[4,5]decan-4-on derivatives, their use, production thereof and medicaments containing the same | |
ZA967920B (en) | Production and use of isolated type 5 17beta-hydroxysteroid dehydrogenase. | |
PL340372A1 (en) | Novel 3,6x-hemiketals of 9a-azalydes class | |
AU7978794A (en) | 3,17-dihydroxy-3,7,16 and/or 17-methyl-androst-5-ene compounds, derivatives thereof, and their use | |
HUP9901376A3 (en) | 1-methylcarbapenem derivatives, their use, production thereof and medicaments containing the same | |
HUP0102025A3 (en) | Derivatives of 1,3,4-oxadiazolone, pharmaceutical compositions containing them and their use | |
HUP9900924A3 (en) | Substituted 1 betha-d-arabinofuranosylcytosine derivatives and use of the same for producing pharmaceutical compositions having antitumor activity | |
NO960699L (en) | Antimigren 1,2,5-thiadiazole derivatives of indolylalkylpyridinyl and pyrimidinylpiperazines | |
AU3467697A (en) | 3'-oximino-2',3'-dideoxynucleosides and derivatives of the same | |
AU6180896A (en) | Improved synthesis of 2,4,6,8,10,12-hexabenzyl-2,4,6,8,10,12-hexaazatetracyclo{5.5 .0.05,9.03,11}dodecane | |
AU6531196A (en) | Triazolone derivatives, use of the same and intermediates in the production of the same | |
AU4361696A (en) | New uses of indolo-{2,3b}-quinoxalines |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
NENP | Non-entry into the national phase |
Ref country code: CA |